0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ambrisentantable Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-26V7704
Home | Market Reports | Health | Health Conditions | Heart & Hypertension
Global Ambrisentantable Market Insights and Forecast to 2028

Global Ambrisentantable Market Insights and Forecast to 2028

Code: QYRE-Auto-26V7704
Report
May 2022
106 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Ambrisentan is an orally active selective type A endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension. It is approved in Europe, Canada and the United States for use as a single agent to improve exercise ability and delay clinical worsening. In addition, it is approved in the United States for use in combination with tadalafil to reduce the risks of disease progression, hospitalization and to improve exercise ability. Studies establishing the efficacy of Ambrisentan included patients with both idiopathic or heritable pulmonary arterial hypertension and those with pulmonary arterial hypertension associated with connective tissue diseases. Patients studied displayed symptoms and etiologies predominantly of WHO Functional Class II-III. As an endothelin receptor antagonist, Ambrisentan prevents endogenous endothelin peptide from constricting the muscles in blood vessels, allowing them to relax and permit a reduction in blood pressure.
Market Analysis and Insights: Global Ambrisentantable Market

Due to the COVID-19 pandemic, the global Ambrisentantable market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, 5 mg Tablet accounting for % of the Ambrisentantable global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Cirrhosis Of The Liver segment is altered to an % CAGR throughout this forecast period.
China Ambrisentantable market size is valued at US$ million in 2021, while the US and Europe Ambrisentantable are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Ambrisentantable landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Ambrisentantable include GSK, Actavis (TEVA ), Gilead Sciences, Mylan Pharmaceuticals, Sigmapharm Laboratories, Noorik BioPharma, Cipla, Cadila Healthcare and Sun Pharmaceutical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ambrisentantable Scope and Segment
Ambrisentantable market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ambrisentantable market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

5 mg Tablet
10 mg Tablet

Segment by Application

Cirrhosis Of The Liver
High Blood Pressure
Hepatorenal Syndrome
Graft Function Is Delayed
Pulmonary Hypertension
Heart Failure
Chronic Renal Failure
Idiopathic Pulmonary Fibrosis
Other

BY COMPANY

GSK
Actavis (TEVA )
Gilead Sciences
Mylan Pharmaceuticals
Sigmapharm Laboratories
Noorik BioPharma
Cipla
Cadila Healthcare
Sun Pharmaceutical Industries
Hansoh Pharma
CTTQ
Zhejiang Haosen Pharmaceutical

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Ambrisentantable Product Introduction
1.2 Market by Type
1.2.1 Global Ambrisentantable Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 5 mg Tablet
1.2.3 10 mg Tablet
1.3 Market by Application
1.3.1 Global Ambrisentantable Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cirrhosis Of The Liver
1.3.3 High Blood Pressure
1.3.4 Hepatorenal Syndrome
1.3.5 Graft Function Is Delayed
1.3.6 Pulmonary Hypertension
1.3.7 Heart Failure
1.3.8 Chronic Renal Failure
1.3.9 Idiopathic Pulmonary Fibrosis
1.3.10 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ambrisentantable Sales Estimates and Forecasts 2017-2028
2.2 Global Ambrisentantable Revenue Estimates and Forecasts 2017-2028
2.3 Global Ambrisentantable Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ambrisentantable Sales by Region
2.4.1 Global Ambrisentantable Sales by Region (2017-2022)
2.4.2 Global Sales Ambrisentantable by Region (2023-2028)
2.5 Global Ambrisentantable Revenue by Region
2.5.1 Global Ambrisentantable Revenue by Region (2017-2022)
2.5.2 Global Ambrisentantable Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ambrisentantable Sales by Manufacturers
3.1.1 Global Top Ambrisentantable Manufacturers by Sales (2017-2022)
3.1.2 Global Ambrisentantable Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ambrisentantable in 2021
3.2 Global Ambrisentantable Revenue by Manufacturers
3.2.1 Global Ambrisentantable Revenue by Manufacturers (2017-2022)
3.2.2 Global Ambrisentantable Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ambrisentantable Revenue in 2021
3.3 Global Ambrisentantable Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ambrisentantable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ambrisentantable Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ambrisentantable Sales by Type
4.1.1 Global Ambrisentantable Historical Sales by Type (2017-2022)
4.1.2 Global Ambrisentantable Forecasted Sales by Type (2023-2028)
4.1.3 Global Ambrisentantable Sales Market Share by Type (2017-2028)
4.2 Global Ambrisentantable Revenue by Type
4.2.1 Global Ambrisentantable Historical Revenue by Type (2017-2022)
4.2.2 Global Ambrisentantable Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ambrisentantable Revenue Market Share by Type (2017-2028)
4.3 Global Ambrisentantable Price by Type
4.3.1 Global Ambrisentantable Price by Type (2017-2022)
4.3.2 Global Ambrisentantable Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ambrisentantable Sales by Application
5.1.1 Global Ambrisentantable Historical Sales by Application (2017-2022)
5.1.2 Global Ambrisentantable Forecasted Sales by Application (2023-2028)
5.1.3 Global Ambrisentantable Sales Market Share by Application (2017-2028)
5.2 Global Ambrisentantable Revenue by Application
5.2.1 Global Ambrisentantable Historical Revenue by Application (2017-2022)
5.2.2 Global Ambrisentantable Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ambrisentantable Revenue Market Share by Application (2017-2028)
5.3 Global Ambrisentantable Price by Application
5.3.1 Global Ambrisentantable Price by Application (2017-2022)
5.3.2 Global Ambrisentantable Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ambrisentantable Market Size by Type
6.1.1 North America Ambrisentantable Sales by Type (2017-2028)
6.1.2 North America Ambrisentantable Revenue by Type (2017-2028)
6.2 North America Ambrisentantable Market Size by Application
6.2.1 North America Ambrisentantable Sales by Application (2017-2028)
6.2.2 North America Ambrisentantable Revenue by Application (2017-2028)
6.3 North America Ambrisentantable Market Size by Country
6.3.1 North America Ambrisentantable Sales by Country (2017-2028)
6.3.2 North America Ambrisentantable Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Ambrisentantable Market Size by Type
7.1.1 Europe Ambrisentantable Sales by Type (2017-2028)
7.1.2 Europe Ambrisentantable Revenue by Type (2017-2028)
7.2 Europe Ambrisentantable Market Size by Application
7.2.1 Europe Ambrisentantable Sales by Application (2017-2028)
7.2.2 Europe Ambrisentantable Revenue by Application (2017-2028)
7.3 Europe Ambrisentantable Market Size by Country
7.3.1 Europe Ambrisentantable Sales by Country (2017-2028)
7.3.2 Europe Ambrisentantable Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ambrisentantable Market Size by Type
8.1.1 Asia Pacific Ambrisentantable Sales by Type (2017-2028)
8.1.2 Asia Pacific Ambrisentantable Revenue by Type (2017-2028)
8.2 Asia Pacific Ambrisentantable Market Size by Application
8.2.1 Asia Pacific Ambrisentantable Sales by Application (2017-2028)
8.2.2 Asia Pacific Ambrisentantable Revenue by Application (2017-2028)
8.3 Asia Pacific Ambrisentantable Market Size by Region
8.3.1 Asia Pacific Ambrisentantable Sales by Region (2017-2028)
8.3.2 Asia Pacific Ambrisentantable Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Ambrisentantable Market Size by Type
9.1.1 Latin America Ambrisentantable Sales by Type (2017-2028)
9.1.2 Latin America Ambrisentantable Revenue by Type (2017-2028)
9.2 Latin America Ambrisentantable Market Size by Application
9.2.1 Latin America Ambrisentantable Sales by Application (2017-2028)
9.2.2 Latin America Ambrisentantable Revenue by Application (2017-2028)
9.3 Latin America Ambrisentantable Market Size by Country
9.3.1 Latin America Ambrisentantable Sales by Country (2017-2028)
9.3.2 Latin America Ambrisentantable Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ambrisentantable Market Size by Type
10.1.1 Middle East and Africa Ambrisentantable Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ambrisentantable Revenue by Type (2017-2028)
10.2 Middle East and Africa Ambrisentantable Market Size by Application
10.2.1 Middle East and Africa Ambrisentantable Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ambrisentantable Revenue by Application (2017-2028)
10.3 Middle East and Africa Ambrisentantable Market Size by Country
10.3.1 Middle East and Africa Ambrisentantable Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ambrisentantable Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Actavis (TEVA )
11.2.1 Actavis (TEVA ) Corporation Information
11.2.2 Actavis (TEVA ) Overview
11.2.3 Actavis (TEVA ) Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Actavis (TEVA ) Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Actavis (TEVA ) Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Corporation Information
11.3.2 Gilead Sciences Overview
11.3.3 Gilead Sciences Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Gilead Sciences Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Gilead Sciences Recent Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Corporation Information
11.4.2 Mylan Pharmaceuticals Overview
11.4.3 Mylan Pharmaceuticals Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Pharmaceuticals Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Pharmaceuticals Recent Developments
11.5 Sigmapharm Laboratories
11.5.1 Sigmapharm Laboratories Corporation Information
11.5.2 Sigmapharm Laboratories Overview
11.5.3 Sigmapharm Laboratories Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sigmapharm Laboratories Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sigmapharm Laboratories Recent Developments
11.6 Noorik BioPharma
11.6.1 Noorik BioPharma Corporation Information
11.6.2 Noorik BioPharma Overview
11.6.3 Noorik BioPharma Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Noorik BioPharma Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Noorik BioPharma Recent Developments
11.7 Cipla
11.7.1 Cipla Corporation Information
11.7.2 Cipla Overview
11.7.3 Cipla Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cipla Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cipla Recent Developments
11.8 Cadila Healthcare
11.8.1 Cadila Healthcare Corporation Information
11.8.2 Cadila Healthcare Overview
11.8.3 Cadila Healthcare Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cadila Healthcare Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cadila Healthcare Recent Developments
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Corporation Information
11.9.2 Sun Pharmaceutical Industries Overview
11.9.3 Sun Pharmaceutical Industries Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sun Pharmaceutical Industries Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sun Pharmaceutical Industries Recent Developments
11.10 Hansoh Pharma
11.10.1 Hansoh Pharma Corporation Information
11.10.2 Hansoh Pharma Overview
11.10.3 Hansoh Pharma Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hansoh Pharma Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hansoh Pharma Recent Developments
11.11 CTTQ
11.11.1 CTTQ Corporation Information
11.11.2 CTTQ Overview
11.11.3 CTTQ Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 CTTQ Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CTTQ Recent Developments
11.12 Zhejiang Haosen Pharmaceutical
11.12.1 Zhejiang Haosen Pharmaceutical Corporation Information
11.12.2 Zhejiang Haosen Pharmaceutical Overview
11.12.3 Zhejiang Haosen Pharmaceutical Ambrisentantable Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Zhejiang Haosen Pharmaceutical Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zhejiang Haosen Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ambrisentantable Industry Chain Analysis
12.2 Ambrisentantable Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ambrisentantable Production Mode & Process
12.4 Ambrisentantable Sales and Marketing
12.4.1 Ambrisentantable Sales Channels
12.4.2 Ambrisentantable Distributors
12.5 Ambrisentantable Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ambrisentantable Industry Trends
13.2 Ambrisentantable Market Drivers
13.3 Ambrisentantable Market Challenges
13.4 Ambrisentantable Market Restraints
14 Key Findings in The Global Ambrisentantable Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Ambrisentantable Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 5 mg Tablet
    Table 3. Major Manufacturers of 10 mg Tablet
    Table 4. Global Ambrisentantable Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Ambrisentantable Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Ambrisentantable Sales by Region (2017-2022) & (M Pcs)
    Table 7. Global Ambrisentantable Sales Market Share by Region (2017-2022)
    Table 8. Global Ambrisentantable Sales by Region (2023-2028) & (M Pcs)
    Table 9. Global Ambrisentantable Sales Market Share by Region (2023-2028)
    Table 10. Global Ambrisentantable Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Ambrisentantable Revenue Market Share by Region (2017-2022)
    Table 12. Global Ambrisentantable Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Ambrisentantable Revenue Market Share by Region (2023-2028)
    Table 14. Global Ambrisentantable Sales by Manufacturers (2017-2022) & (M Pcs)
    Table 15. Global Ambrisentantable Sales Share by Manufacturers (2017-2022)
    Table 16. Global Ambrisentantable Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Ambrisentantable Revenue Share by Manufacturers (2017-2022)
    Table 18. Ambrisentantable Price by Manufacturers (2017-2022) &(US$/Pcs)
    Table 19. Global Ambrisentantable Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Ambrisentantable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ambrisentantable as of 2021)
    Table 21. Ambrisentantable Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Ambrisentantable Product Offered
    Table 23. Date of Manufacturers Enter into Ambrisentantable Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Ambrisentantable Sales by Type (2017-2022) & (M Pcs)
    Table 26. Global Ambrisentantable Sales by Type (2023-2028) & (M Pcs)
    Table 27. Global Ambrisentantable Sales Share by Type (2017-2022)
    Table 28. Global Ambrisentantable Sales Share by Type (2023-2028)
    Table 29. Global Ambrisentantable Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Ambrisentantable Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Ambrisentantable Revenue Share by Type (2017-2022)
    Table 32. Global Ambrisentantable Revenue Share by Type (2023-2028)
    Table 33. Ambrisentantable Price by Type (2017-2022) & (US$/Pcs)
    Table 34. Global Ambrisentantable Price Forecast by Type (2023-2028) & (US$/Pcs)
    Table 35. Global Ambrisentantable Sales by Application (2017-2022) & (M Pcs)
    Table 36. Global Ambrisentantable Sales by Application (2023-2028) & (M Pcs)
    Table 37. Global Ambrisentantable Sales Share by Application (2017-2022)
    Table 38. Global Ambrisentantable Sales Share by Application (2023-2028)
    Table 39. Global Ambrisentantable Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Ambrisentantable Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Ambrisentantable Revenue Share by Application (2017-2022)
    Table 42. Global Ambrisentantable Revenue Share by Application (2023-2028)
    Table 43. Ambrisentantable Price by Application (2017-2022) & (US$/Pcs)
    Table 44. Global Ambrisentantable Price Forecast by Application (2023-2028) & (US$/Pcs)
    Table 45. North America Ambrisentantable Sales by Type (2017-2022) & (M Pcs)
    Table 46. North America Ambrisentantable Sales by Type (2023-2028) & (M Pcs)
    Table 47. North America Ambrisentantable Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Ambrisentantable Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Ambrisentantable Sales by Application (2017-2022) & (M Pcs)
    Table 50. North America Ambrisentantable Sales by Application (2023-2028) & (M Pcs)
    Table 51. North America Ambrisentantable Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Ambrisentantable Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Ambrisentantable Sales by Country (2017-2022) & (M Pcs)
    Table 54. North America Ambrisentantable Sales by Country (2023-2028) & (M Pcs)
    Table 55. North America Ambrisentantable Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Ambrisentantable Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Ambrisentantable Sales by Type (2017-2022) & (M Pcs)
    Table 58. Europe Ambrisentantable Sales by Type (2023-2028) & (M Pcs)
    Table 59. Europe Ambrisentantable Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Ambrisentantable Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Ambrisentantable Sales by Application (2017-2022) & (M Pcs)
    Table 62. Europe Ambrisentantable Sales by Application (2023-2028) & (M Pcs)
    Table 63. Europe Ambrisentantable Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Ambrisentantable Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Ambrisentantable Sales by Country (2017-2022) & (M Pcs)
    Table 66. Europe Ambrisentantable Sales by Country (2023-2028) & (M Pcs)
    Table 67. Europe Ambrisentantable Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Ambrisentantable Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Ambrisentantable Sales by Type (2017-2022) & (M Pcs)
    Table 70. Asia Pacific Ambrisentantable Sales by Type (2023-2028) & (M Pcs)
    Table 71. Asia Pacific Ambrisentantable Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Ambrisentantable Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Ambrisentantable Sales by Application (2017-2022) & (M Pcs)
    Table 74. Asia Pacific Ambrisentantable Sales by Application (2023-2028) & (M Pcs)
    Table 75. Asia Pacific Ambrisentantable Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Ambrisentantable Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Ambrisentantable Sales by Region (2017-2022) & (M Pcs)
    Table 78. Asia Pacific Ambrisentantable Sales by Region (2023-2028) & (M Pcs)
    Table 79. Asia Pacific Ambrisentantable Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Ambrisentantable Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Ambrisentantable Sales by Type (2017-2022) & (M Pcs)
    Table 82. Latin America Ambrisentantable Sales by Type (2023-2028) & (M Pcs)
    Table 83. Latin America Ambrisentantable Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Ambrisentantable Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Ambrisentantable Sales by Application (2017-2022) & (M Pcs)
    Table 86. Latin America Ambrisentantable Sales by Application (2023-2028) & (M Pcs)
    Table 87. Latin America Ambrisentantable Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Ambrisentantable Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Ambrisentantable Sales by Country (2017-2022) & (M Pcs)
    Table 90. Latin America Ambrisentantable Sales by Country (2023-2028) & (M Pcs)
    Table 91. Latin America Ambrisentantable Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Ambrisentantable Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Ambrisentantable Sales by Type (2017-2022) & (M Pcs)
    Table 94. Middle East and Africa Ambrisentantable Sales by Type (2023-2028) & (M Pcs)
    Table 95. Middle East and Africa Ambrisentantable Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Ambrisentantable Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Ambrisentantable Sales by Application (2017-2022) & (M Pcs)
    Table 98. Middle East and Africa Ambrisentantable Sales by Application (2023-2028) & (M Pcs)
    Table 99. Middle East and Africa Ambrisentantable Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Ambrisentantable Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Ambrisentantable Sales by Country (2017-2022) & (M Pcs)
    Table 102. Middle East and Africa Ambrisentantable Sales by Country (2023-2028) & (M Pcs)
    Table 103. Middle East and Africa Ambrisentantable Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Ambrisentantable Revenue by Country (2023-2028) & (US$ Million)
    Table 105. GSK Corporation Information
    Table 106. GSK Description and Major Businesses
    Table 107. GSK Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 108. GSK Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. GSK Recent Developments
    Table 110. Actavis (TEVA ) Corporation Information
    Table 111. Actavis (TEVA ) Description and Major Businesses
    Table 112. Actavis (TEVA ) Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 113. Actavis (TEVA ) Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Actavis (TEVA ) Recent Developments
    Table 115. Gilead Sciences Corporation Information
    Table 116. Gilead Sciences Description and Major Businesses
    Table 117. Gilead Sciences Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 118. Gilead Sciences Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Gilead Sciences Recent Developments
    Table 120. Mylan Pharmaceuticals Corporation Information
    Table 121. Mylan Pharmaceuticals Description and Major Businesses
    Table 122. Mylan Pharmaceuticals Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 123. Mylan Pharmaceuticals Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Mylan Pharmaceuticals Recent Developments
    Table 125. Sigmapharm Laboratories Corporation Information
    Table 126. Sigmapharm Laboratories Description and Major Businesses
    Table 127. Sigmapharm Laboratories Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 128. Sigmapharm Laboratories Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Sigmapharm Laboratories Recent Developments
    Table 130. Noorik BioPharma Corporation Information
    Table 131. Noorik BioPharma Description and Major Businesses
    Table 132. Noorik BioPharma Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 133. Noorik BioPharma Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Noorik BioPharma Recent Developments
    Table 135. Cipla Corporation Information
    Table 136. Cipla Description and Major Businesses
    Table 137. Cipla Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 138. Cipla Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Cipla Recent Developments
    Table 140. Cadila Healthcare Corporation Information
    Table 141. Cadila Healthcare Description and Major Businesses
    Table 142. Cadila Healthcare Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 143. Cadila Healthcare Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Cadila Healthcare Recent Developments
    Table 145. Sun Pharmaceutical Industries Corporation Information
    Table 146. Sun Pharmaceutical Industries Description and Major Businesses
    Table 147. Sun Pharmaceutical Industries Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 148. Sun Pharmaceutical Industries Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Sun Pharmaceutical Industries Recent Developments
    Table 150. Hansoh Pharma Corporation Information
    Table 151. Hansoh Pharma Description and Major Businesses
    Table 152. Hansoh Pharma Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 153. Hansoh Pharma Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Hansoh Pharma Recent Developments
    Table 155. CTTQ Corporation Information
    Table 156. CTTQ Description and Major Businesses
    Table 157. CTTQ Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 158. CTTQ Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. CTTQ Recent Developments
    Table 160. Zhejiang Haosen Pharmaceutical Corporation Information
    Table 161. Zhejiang Haosen Pharmaceutical Description and Major Businesses
    Table 162. Zhejiang Haosen Pharmaceutical Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 163. Zhejiang Haosen Pharmaceutical Ambrisentantable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Zhejiang Haosen Pharmaceutical Recent Developments
    Table 165. Key Raw Materials Lists
    Table 166. Raw Materials Key Suppliers Lists
    Table 167. Ambrisentantable Distributors List
    Table 168. Ambrisentantable Customers List
    Table 169. Ambrisentantable Market Trends
    Table 170. Ambrisentantable Market Drivers
    Table 171. Ambrisentantable Market Challenges
    Table 172. Ambrisentantable Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ambrisentantable Product Picture
    Figure 3. Global Ambrisentantable Market Share by Type in 2021 & 2028
    Figure 3. 5 mg Tablet Product Picture
    Figure 4. 10 mg Tablet Product Picture
    Figure 5. Global Ambrisentantable Market Share by Application in 2021 & 2028
    Figure 6. Cirrhosis Of The Liver
    Figure 7. High Blood Pressure
    Figure 8. Hepatorenal Syndrome
    Figure 9. Graft Function Is Delayed
    Figure 10. Pulmonary Hypertension
    Figure 11. Heart Failure
    Figure 12. Chronic Renal Failure
    Figure 13. Idiopathic Pulmonary Fibrosis
    Figure 14. Other
    Figure 15. Ambrisentantable Report Years Considered
    Figure 16. Global Ambrisentantable Sales 2017-2028 (M Pcs)
    Figure 17. Global Ambrisentantable Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Ambrisentantable Revenue 2017-2028 (US$ Million)
    Figure 19. Global Ambrisentantable Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 20. Global Ambrisentantable Sales Market Share by Region (2017-2022)
    Figure 21. Global Ambrisentantable Sales Market Share by Region (2023-2028)
    Figure 22. North America Ambrisentantable Sales YoY (2017-2028) & (M Pcs)
    Figure 23. North America Ambrisentantable Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Ambrisentantable Sales YoY (2017-2028) & (M Pcs)
    Figure 25. Europe Ambrisentantable Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Ambrisentantable Sales YoY (2017-2028) & (M Pcs)
    Figure 27. Asia-Pacific Ambrisentantable Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Latin America Ambrisentantable Sales YoY (2017-2028) & (M Pcs)
    Figure 29. Latin America Ambrisentantable Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Middle East & Africa Ambrisentantable Sales YoY (2017-2028) & (M Pcs)
    Figure 31. Middle East & Africa Ambrisentantable Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. The Ambrisentantable Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 33. The Top 5 and 10 Largest Manufacturers of Ambrisentantable in the World: Market Share by Ambrisentantable Revenue in 2021
    Figure 34. Global Ambrisentantable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 35. Global Ambrisentantable Sales Market Share by Type (2017-2028)
    Figure 36. Global Ambrisentantable Revenue Market Share by Type (2017-2028)
    Figure 37. Global Ambrisentantable Sales Market Share by Application (2017-2028)
    Figure 38. Global Ambrisentantable Revenue Market Share by Application (2017-2028)
    Figure 39. North America Ambrisentantable Sales Market Share by Type (2017-2028)
    Figure 40. North America Ambrisentantable Revenue Market Share by Type (2017-2028)
    Figure 41. North America Ambrisentantable Sales Market Share by Application (2017-2028)
    Figure 42. North America Ambrisentantable Revenue Market Share by Application (2017-2028)
    Figure 43. North America Ambrisentantable Sales Share by Country (2017-2028)
    Figure 44. North America Ambrisentantable Revenue Share by Country (2017-2028)
    Figure 45. U.S. Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 46. Canada Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 47. Europe Ambrisentantable Sales Market Share by Type (2017-2028)
    Figure 48. Europe Ambrisentantable Revenue Market Share by Type (2017-2028)
    Figure 49. Europe Ambrisentantable Sales Market Share by Application (2017-2028)
    Figure 50. Europe Ambrisentantable Revenue Market Share by Application (2017-2028)
    Figure 51. Europe Ambrisentantable Sales Share by Country (2017-2028)
    Figure 52. Europe Ambrisentantable Revenue Share by Country (2017-2028)
    Figure 53. Germany Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 54. France Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 55. U.K. Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 56. Italy Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 57. Russia Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 58. Asia Pacific Ambrisentantable Sales Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Ambrisentantable Revenue Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Ambrisentantable Sales Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Ambrisentantable Revenue Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Ambrisentantable Sales Share by Region (2017-2028)
    Figure 63. Asia Pacific Ambrisentantable Revenue Share by Region (2017-2028)
    Figure 64. China Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 65. Japan Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 66. South Korea Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 67. India Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 68. Australia Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 69. Taiwan Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 70. Indonesia Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 71. Thailand Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 72. Malaysia Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 73. Philippines Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 74. Latin America Ambrisentantable Sales Market Share by Type (2017-2028)
    Figure 75. Latin America Ambrisentantable Revenue Market Share by Type (2017-2028)
    Figure 76. Latin America Ambrisentantable Sales Market Share by Application (2017-2028)
    Figure 77. Latin America Ambrisentantable Revenue Market Share by Application (2017-2028)
    Figure 78. Latin America Ambrisentantable Sales Share by Country (2017-2028)
    Figure 79. Latin America Ambrisentantable Revenue Share by Country (2017-2028)
    Figure 80. Mexico Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 81. Brazil Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 82. Argentina Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 83. Middle East and Africa Ambrisentantable Sales Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Ambrisentantable Revenue Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Ambrisentantable Sales Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Ambrisentantable Revenue Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Ambrisentantable Sales Share by Country (2017-2028)
    Figure 88. Middle East and Africa Ambrisentantable Revenue Share by Country (2017-2028)
    Figure 89. Turkey Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 90. Saudi Arabia Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 91. UAE Ambrisentantable Revenue (2017-2028) & (US$ Million)
    Figure 92. Ambrisentantable Value Chain
    Figure 93. Ambrisentantable Production Process
    Figure 94. Channels of Distribution
    Figure 95. Distributors Profiles
    Figure 96. Bottom-up and Top-down Approaches for This Report
    Figure 97. Data Triangulation
    Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global and United States Pacemakers and Implantable Cardioverter Defibrillators Market Report Forecast 2022 2028
Global and United States Pacemakers and Implantable Cardioverter Defibrillators Market Report & Forecast 2022-2028

An implantable cardioverterdefibrillator is a specialized implantable electronic device designed to directly treat a cardiac tachyarrhythmia whereas a permanent pacemaker is an implanted device that provides electrical stimuli.Market Analysis and Insights Global and United States Pacemakers and Implantable Cardioverter Defibrillators MarketThis report focuses on global and United States Pacemakers and Implantable Cardioverter Defibrillators market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Pacemakers and Implantable Cardioverter Defibrillators market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-11P10580
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Peripheral Vascular Surgical Devices Market Report Forecast 2022 2028
Global and United States Peripheral Vascular Surgical Devices Market Report & Forecast 2022-2028

Peripheral vascular surgical devices refer to special medical devices used in vascular surgery interventional cardiology interventional radiology and peripheral vascular procedures.Market Analysis and Insights Global and United States Peripheral Vascular Surgical Devices MarketThis report focuses on global and United States Peripheral Vascular Surgical Devices market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Peripheral Vascular Surgical Devices market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-8N10687
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Coronary Stent Devices Market Report Forecast 2022 2028
Global and United States Coronary Stent Devices Market Report & Forecast 2022-2028

Coronary stents are tubelike expandable metallic devices which are introduced into coronary arteries that are clogged due to an underlying atherosclerosis disease.Market Analysis and Insights Global and United States Coronary Stent Devices MarketThis report focuses on global and United States Coronary Stent Devices market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Coronary Stent Devices market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-33O10296
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Stroke Treatment Drugs Market Report Forecast 2022 2028
Global and United States Stroke Treatment Drugs Market Report & Forecast 2022-2028

Stroke is a disruption in brain function caused by lack of blood flow to the brain.Market Analysis and Insights Global and United States Stroke Treatment Drugs MarketThis report focuses on global and United States Stroke Treatment Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Stroke Treatment Drugs market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-27B10301
Tue Jun 07 00:00:00 UTC 2022

Add to Cart